Fresenius Medical Care Underweight from JP Morgan Chase & Co. on 10/21/24

NEW YORK (dpa-AFX Analyzer) – The American bank JPMorgan has implemented a Fresenius Medical Care Program (FMC) to assess the “Underweight” with a price of 35.40 euros. The treatment methods study was authored by Quartal in the positive field, and analyst David Adlington worked on a mounting study for the application of dialysis guidelines./ajx/mis

Veröffentlichung der Original-Studie: 18.10.2024 / 20:01 / BST First publication of the original-Studie: 21.10.2024 / 00:15 / BST

Note: Information on Offenlegungspflicht bei Interessenkonflikten im Sinne von § 85 Abs. 1 WpHG, art. 20 VO (EU) 596/2014 for the House of General Analysts, found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.